Want to join the conversation?
Eric Sheridan of UBS asks about EBITDA margin leverage driver in 1Q16. $TWTR said the company had a strong quarter on the profitability front. The quarter reinforces the company's belief of the opportunity to drive long-term margin of 40-45% on an EBITDA basis relative to net revenue.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?